Thompson Kimberly Kraig's Form 4 filing
Kraig Biocraft Laboratories, Inc. (KBLB) · filed Jul 19, 2022
- Accession no.
- 0001493152-22-019832
- Filed
- Jul 19, 2022
- Trade date
- Jul 15-18, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Kimberly KraigCIK 0001837586 | Director, Officer (CEO & CFO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | Common Stock | SSaleDisposed | −50,000 | – | – | 201,837,824 | Direct | |
| Jul 18, 2022 | Common Stock | SSaleDisposed | −79,900 | – | – | 201,757,924 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.